Autistic-like phenotypes in Cadps2-knockout mice and aberrant CADPS2 splicing in autistic patients

Journal of Clinical Investigation

Volumn 117, Issue 4, 2007, Pages 931-943

  Sadakata, Tetsushi ^a   Washida, Miwa ^a   Iwayama, Yoshimi ^a   Shoji, Satoshi ^a   Sato, Yumi ^a   Ohkura, Takeshi ^b   Katoh Semba, Ritsuko ^c   Nakajima, Mizuho ^a   Sekine, Yukiko ^a   Tanaka, Mika ^a   Nakamura, Kazuhiko ^d   Iwata, Yasuhide ^d   Tsuchiya, Kenji J ^d   Mori, Norio ^d   Detera Wadleigh, Sevilla D ^e   Ichikawa, Hironobu ^b   Itohara, Shigeyoshi ^a   Yoshikawa, Takeo ^a   Furuichi, Teiichi ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b TOKYO METROPOLITAN CHILDREN'S MEDICAL CENTER   (Japan)

^c INSTITUTE FOR DEVELOPMENTAL RESEARCH   (Japan)

^d HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM DEPENDENT ACTIVATOR PROTEIN FOR SECRETION 2; DYNACTIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; AUTISM; CHROMOSOME 7Q; CONTROLLED STUDY; FEMALE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROCESSING;

ALTERNATIVE SPLICING; ANIMALS; AUTISTIC DISORDER; CALCIUM-BINDING PROTEINS; CELL DEATH; CHROMOSOME ABERRATIONS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MATERNAL BEHAVIOR; MICE; MICE, KNOCKOUT; PURKINJE CELLS; SEQUENCE DELETION; VESICULAR TRANSPORT PROTEINS;

EID: 33847788692     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI29031     Document Type: Article

References (62)

1. World Health Organization. 1992. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization. Geneva, Switzerland. http://www.who.int/substance_abuse/ terminology/ icd_10/en/index.html.
2. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders: DSM-IV. American Psychiatric Publishing Inc. Washington, DC, USA. 886 pp.
3. Muhle, R., Trentacoste, S.V., and Rapin, I. 2004. The genetics of autism. Pediatrics. 113:e472-e486.
4. Folstein, S.E., and Rosen-Sheidley, B. 2001. Genetics of autism: complex aetiology for a heterogeneous disorder. Nat. Rev. Genet. 2:943-955.
5. Jamain, S., et al. 2003. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 34:27-29.
6. Kwon, C.H., et al. 2006. Pten regulates neuronal arborization and social interaction in mice. Neuron. 50:377-388.
7. International Molecular Genetic Study of Autism Consortium (IMGSAC). 2001. Further characterization of the autism susceptibility locus AUTS1 on chromosome 7q. Hum. Mol. Genet. 10:973-982.
8. 2 binding protein. Neuron. 43:551-562.
9. 2+-dependent activator for secretion protein family. Genomics. 81:279-291.
10. Sadakata, T., et al. 2004. The secretory granuleassociated protein CAPS2 regulates neurotrophin release and cell survival. J. Neurosci. 24:43-52.
11. 2+ -dependent activator protein for secretion family proteins (CAPS2 and CAPS1) in the mouse brain. J. Comp. Neurol. 495:735-753.
12. Bibel, M., and Barde, Y.A. 2000. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev. 14:2919-2937.
13. Lu, B. 2003. BDNF and activity-dependent synaptic modulation. Learn. Mem. 10:86-98.
14. Lessmann, V., Gottmann, K., and Malcangio, M. 2003. Neurotrophin secretion: current facts and future prospects. Prog. Neurobiol. 69:341-374.
15. Amir, R.E., et al. 1999. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23:185-188.
16. Chang, Q., Khare, G., Dani, V., Nelson, S., and Jaenisch, R. 2006. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron. 49:341-348.
17. Aman, M.G., and Langworthy, K.S. 2000. Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders. J. Autism Dev. Disord. 30:451-459.
18. Aman, M.G. 2004. Management of hyperactivity and other acting-out problems in patients with autism spectrum disorder. Semin. Pediatr. Neurol. 11:225-228.
19. Pierce, K., and Courchesne, E. 2001. Evidence for a cerebellar role in reduced exploration and stereotyped behavior in autism. Biol. Psychiatry. 49:655-664.
20. Filipek, P.A., et al. 2000. Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology. 55:468-479.
21. Richdale, A.L., and Prior, M.R. 1995. The sleep/wake rhythm in children with autism. Eur. Child Adolesc. Psychiatry. 4:175-186.
22. Montgomery, K.C. 1955. The relation between fear induced by novel stimulation and exploratory behavior. J. Comp. Physiol. Psychol. 48:254-260.
23. Casanova, M.F., Buxhoeveden, D., and Gomez, J. 2003. Disruption in the inhibitory architecture of the cell minicolumn: implications for autisim. Neuroscientist. 9:496-507.
24. Jones, K.R., Farinas, I., Backus, C., and Reichardt, L.F. 1994. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell. 76:989-999.
25. Bauman, M., and Kemper, T.L. 1985. Histoanatomic observations of the brain in early infantile autism. Neurology. 35:866-874.
26. Sato, Y., Shiraishi, Y., and Furuichi, T. 2004. Cell specificity and efficiency of the Semliki forest virus vector- and adenovirus vector-mediated gene expression in mouse cerebellum. J. Neurosci. Methods. 137:111-121.
27. Ogawa, H., et al. 2003. A SWI2/SNF2-type ATPase/ helicase protein, mDomino, interacts with myeloid zinc finger protein 2A (MZF-2A) to regulate its transcriptional activity. Genes Cells. 8:325-339.
28. Shibata, N., et al. 2004. Mouse RanBPM is a partner gene to a germline specific RNA helicase, mouse vasa homolog protein. Mol. Reprod. Dev. 67:1-7.
29. Schroer, T.A. 2004. Dynactin. Annu. Rev. Cell Dev. Biol. 20:759-779.
30. 2+-dependent activator proteins for secretion: comparative analysis of structure, expression, localization, and function. J. Biol. Chem. 278:52802-52809.
31. Waterman-Storer, C.M., et al. 1997. The interaction between cytoplasmic dynein and dynactin is required for fast axonal transport. Proc. Natl. Acad. Sci. U. S. A. 94:12180-12185.
32. Deacon, S.W., et al. 2003. Dynactin is required for bidirectional organelle transport. J. Cell Biol. 160:297-301.
33. Burack, M.A., Silverman, M.A., and Banker, G. 2000. The role of selective transport in neuronal protein sorting. Neuron. 26:465-472.
34. Detera-Wadleigh, S.D., et al. 1999. A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. Proc. Natl. Acad. Sci. U. S. A. 96:5604-5609.
35. Detera-Wadleigh, S.D., et al. 1997. Initial genome scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 4, 7, 9, 18, 19, 20, and 21q. Am. J. Med. Genet. 74:254-262.
36. 2+-regulated secretion in permeable neuroendocrine cells. Cell. 70:765-775.
37. Berwin, B., Floor, E., and Martin, T.F. 1998. CAPS (mammalian UNC-31) protein localizes to membranes involved in dense-core vesicle exocytosis. Neuron. 21:137-145.
38. Tandon, A., et al. 1998. Differential regulation of exocytosis by calcium and CAPS in semi-intact synaptosomes. Neuron. 21:147-154.
39. Renden, R., et al. 2001. Drosophila CAPS is an essential gene that regulates dense-core vesicle release and synaptic vesicle fusion. Neuron. 31:421-437.
40. Speidel, D., et al. 2005. CAPS1 regulates catecholamine loading of large dense-core vesicles. Neuron. 46:75-88.
41. Brandeis, R., Brandys, Y., and Yehuda, S. 1989. The use of the Morris Water Maze in the study of memory and learning. Int. J. Neurosci. 48:29-69.
42. Dulawa, S.C., Grandy, D.K., Low, M.J., Paulus, M.P., and Geyer, M.A. 1999. Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J. Neurosci. 19:9550-9556.
43. Levin, E.D., and Bowman, R.E. 1986. Effects of the dopamine D-2 receptor agonist, LY 171555, on radial arm maze performance in rats. Pharmacol. Biochem. Behav. 25:1117-1119.
44. Breese, G.R., and Mueller, R.A. 1985. SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons. Eur. J. Pharmacol. 113:109-114.
45. Binda, A.V., Kabbani, N., and Levenson, R. 2005. Regulation of dense core vesicle release from PC12 cells by interaction between the D2 dopamine receptor and calcium-dependent activator protein for secretion (CAPS). Biochem. Pharmacol. 69:1451-1461.
46. Miyazaki, K., et al. 2004. Serum neurotrophin concentrations in autism and mental retardation: a pilot study. Brain Dev. 26:292-295.
47. Nelson, K.B., et al. 2001. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann. Neurol. 49:597-606.
48. Connolly, A.M., et al. 2006. Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol. Psychiatry. 59:354-363.
49. Nelson, P.G., et al. 2006. Selected neurotrophins, neuropeptides, and cytokines: developmental trajectory and concentrations in neonatal blood of children with autism or Down syndrome. Int. J. Dev. Neurosci. 24:73-80.
50. Hashimoto, K., et al. 2006. Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism. Prog. Neuropsychopharmacol. Biol. Psychiatry. 30:1529-1531.
51. Courchesne, E., and Pierce, K. 2005. Why the frontal cortex in autism might be talking only to itself: local over-connectivity but long-distance disconnection. Curr. Opin. Neurobiol. 15:225-230.
52. Chen, W.G., et al. 2003. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science. 302:885-889.
53. Martinowich, K., et al. 2003. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science. 302:890-893.
54. Lord, C., Rutter, M., and Le Couteur, A. 1994. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J. Autism Dev. Disord. 24:659-685.
55. Kawase, E., et al. 1994. Strain difference in establishment of mouse embryonic stem (ES) cell lines. Int. J. Dev. Biol. 38:385-390.
56. Han, B.H., and Holtzman, D.M. 2000. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J. Neurosci. 20:5775-5781.
57. Nawa, H., Pelleymounter, M.A., and Carnahan, J. 1994. Intraventricular administration of BDNF increases neuropeptide expression in newborn rat brain. J. Neurosci. 14:3751-3765.
58. Fukuda, D., Sata, M., Tanaka, K., and Nagai, R. 2005. Potent inhibitory effect of sirolimus on circulating vascular progenitor cells. Circulation. 111:926-931.
59. Mizushima, S., and Nagata, S. 1990. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18:5322.
60. Miyake, S., et al. 1996. Efficient generation of recombinant adenoviruses using adenovirus DNAterminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. U. S. A. 93:1320-1324.
61. Kanegae, Y., Makimura, M., and Saito, I. 1994. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn. J. Med. Sci. Biol. 47:157-166.
62. Katoh-Semba, R., Takeuchi, I.K., Semba, R., and Kato, K. 2000. Neurotrophin-3 controls proliferation of granular precursors as well as survival of mature granule neurons in the developing rat cerebellum. J. Neurochem. 74:1923-1930.